Tenax Therapeutics (TENX) Income towards Parent Company (2016)
Historic Income towards Parent Company for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to -$34.3 million.
- Tenax Therapeutics' Income towards Parent Company fell 18307.41% to -$34.3 million in Q4 2016 from the same period last year, while for Sep 2017 it was -$34.3 million, marking a year-over-year decrease of 6104.01%. This contributed to the annual value of -$17.6 million for FY2024, which is 12643.43% down from last year.
- Tenax Therapeutics' Income towards Parent Company amounted to -$34.3 million in Q4 2016, which was down 18307.41% from -$4.5 million recorded in Q3 2016.
- Tenax Therapeutics' 5-year Income towards Parent Company high stood at $108.6 million for Q2 2012, and its period low was -$118.0 million during Q2 2013.
- Its 4-year average for Income towards Parent Company is -$8.0 million, with a median of -$4.6 million in 2016.
- Data for Tenax Therapeutics' Income towards Parent Company shows a peak YoY increase of 371057.81% (in 2012) and a maximum YoY decrease of 35790.41% (in 2012) over the last 5 years.
- Over the past 4 years, Tenax Therapeutics' Income towards Parent Company (Quarter) stood at -$1.6 million in 2012, then plummeted by 7512.64% to -$118.0 million in 2013, then skyrocketed by 89.74% to -$12.1 million in 2015, then tumbled by 183.07% to -$34.3 million in 2016.
- Its Income towards Parent Company was -$34.3 million in Q4 2016, compared to -$4.5 million in Q3 2016 and -$4.7 million in Q2 2016.